Prognostic significance of enlarged paraaortic lymph nodes detected during left-sided colorectal cancer surgery: a single-center retrospective cohort study
verfasst von:
Jaram Lee, Hyeong-min Park, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
Very few studies have been conducted on the treatment strategy for enlarged paraaortic lymph nodes (PALNs) incidentally detected during surgery. The purpose of this study was to investigate the benefit of lymph node dissection in patients with incidentally detected enlarged PALNs.
Methods
We retrospectively reviewed patients with left colon and rectal cancer who underwent surgical resection with PALN dissection between January 2010 and December 2018. The predictive factors for pathologic PALN metastasis (PALNM) were analyzed, and survival analyses were conducted to identify prognostic factors.
Results
Among 263 patients included, 19 (7.2%) showed pathologic PALNM and 5 (26.33%) had enlarged PALNs incidentally detected during surgery. These 5 patients accounted for 2.2% of 227 patients who had no evidence of PALNM on preoperative radiologic examination. Radiologic PALNM (odds ratio [OR] 12.737, 95% confidence interval [CI] 3.472–46.723) and radiologic distant metastasis other than PALNM (OR = 4.090, 95% CI 1.011–16.539) were independent predictive factors for pathologic PALNM. Pathologic T4 stage (hazard ratio [HR] 2.196, 95% CI 1.063–4.538) and R2 resection (HR 4.643, 95% CI 2.046–10.534) were independent prognostic factors for overall survival (OS). In patients undergoing R0 resection, pathologic PALNM was not associated with 5-year OS (90% vs. 82.2%, p = 0.896).
Conclusion
Dissection of enlarged PALNs incidentally detected during colorectal surgery may benefit patients with favorable survival outcomes.
Hinweise
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AJCC
American joint committee on cancer
CEA
Carcinoembryonic antigen
CT
Computed tomography
HR
Hazard ratio
OR
Odds ratio
OS
Overall survival
PALNs
Paraaortic lymph nodes
PALNM
Paraaortic lymph node metastasis
PALND
Paraaortic lymph node dissection
PET
Positron emission tomography
Introduction
Colorectal cancer is the third most common cancer in men and the second most common cancer in women, with 1.8 million new cases in 2018 according to the World Health Organization GLOBOCAN database [1]. Approximately 22% of patients with colorectal cancer are diagnosed at stage IV. The 5-year relative survival of colorectal cancer patients of all stages is approximately 67%, whereas the 5-year relative survival of stage IV patients is only 15% [2].
According to the American Joint Committee on Cancer (AJCC) classification, paraaortic lymph node (PALN) metastasis (PALNM) is categorized as distant metastasis (M1), and therefore stage IV [3]. PALNM occurs in approximately 2% of colorectal cancer patients [4]. Previous studies have shown that patients with PALNM have a significantly lower survival rate than those without PALNM [5‐8]. Although several studies have shown that PALN dissection (PALND) improves survival in patients with PALNM, there has been no clearly defined standard treatment for PALNM. Moreover, very few studies have been conducted on the treatment strategy for enlarged PALNs incidentally detected during colorectal cancer surgery.
Anzeige
Therefore, we designed this study to investigate the probability of pathologic PALNM and the benefit of PALND in patients with enlarged PALNs incidentally detected during colorectal cancer surgery.
Methods
We retrospectively reviewed patients with primary colorectal cancer who underwent surgical resection at our institution between January 2010 and December 2018. This study was approved by the institutional review board of our institution (CNUHH-2020-157).
Patients with left-sided colon and rectal cancer who underwent colorectal surgery with PALND were included in this study. We included all patients with retrieved PALNs regardless of whether or not PALNM was suspected on preoperative radiologic examination. Patients without suspected PALNM in the preoperative imaging study were classified into the incidentally detected PALN group.
The clinicopathologic factors of the included patients were retrospectively collected through a review of medical records, which included demographic data, preoperative evaluation, operative findings, pathologic characteristics, and postoperative outcomes. Preoperative evaluation included serum levels of carcinoembryonic antigen (CEA), colonoscopy, abdominopelvic computed tomography (CT), and rectal magnetic resonance imaging. Positron emission tomography (PET) was selectively performed when distant metastasis was suspected. PALNM was suspected when the PALN was > 8 mm or > 5 mm and showed heterogeneity and an irregular outer border on abdominopelvic CT scan. In PET-CT, the presence of PALNs with higher fluorodeoxyglucose uptake than adjacent normal organs was considered to indicate PALNM.
Anzeige
All patients underwent mechanical bowel preparation before surgery. Second-generation cephalosporin was routinely administered within 1 h before surgery as an empirical antibiotics. In most cases, D3 dissection with high ligation of the inferior mesenteric artery was performed. For tumors below the peritoneal reflection, total mesorectal excision was performed. The detailed surgical technique has been previously described [9].
The extent of PALND was determined at the surgeon’s discretion. In cases of highly suspicious PALNM, the PALNs were dissected from the aortic bifurcation to the lower border of the renal vein. In some cases with a single suspicious metastatic PALN, only the suspicious PALN was dissected. In most cases, the surgical procedure including PALND was performed using a laparoscopic approach.
R0 resection was defined as no macroscopic or microscopic residual tumor after surgery, and with no remnant tumor observed on follow-up radiologic examination. R2 resection was defined as a gross residual tumor remaining after surgery or a remnant tumor observed on the first follow-up CT. Histopathologic examination was performed by a specialized pathologist according to standard procedures. The classification system of the AJCC (seventh edition) was used to determine the pathologic stage. Adjuvant chemotherapy was recommended for advanced colorectal cancer, after considering the patient’s general condition. Follow-up examinations included chest CT, abdominopelvic CT, and serum CEA test every 6 months and colonoscopy every 2 years. Recurrence was defined as recurrent disease on clinical, radiologic, or pathologic examination. Overall survival (OS) was defined as the period from surgery to death from any cause.
Categorical variables were compared using the χ2 test or Fisher’s exact test, and continuous variables were compared using Student’s t test. Logistic regression analysis was used to investigate the predictive factors for PALNM. Survival outcomes were compared using the Kaplan–Meier method and log-rank test. Multivariate analysis with a Cox proportional hazard model was used to identify prognostic factors for OS. Variables that were significant at p < 0.10 in the univariate analysis were entered into a multivariate model. Statistical significance was set at p < 0.05. All statistical analyses were performed using IBM SPSS version 23 (IBM, Armonk, NY).
Results
A total of 263 patients with left colon and rectal cancer who underwent PALND were included, and 19 (7.2%) of them showed pathologic PALNM. Of these 19 patients, 14 (73.7%) were suspected to have PALNM on preoperative radiologic examination, and 5 (26.3%) had enlarged PALNs incidentally detected during surgery. These 5 patients accounted for 2.2% of the 227 patients who had no evidence of PALNM on preoperative radiologic examination (Fig. 1). Frozen-section biopsy for PALNs was performed in 29 (11.0%) of the 263 included patients. Of the 29 patients, 5 (17.2%) had metastatic adenocarcinoma in frozen-section analysis, 4 of whom had suspicious PALNM on preoperative imaging study.
Fig. 1
Study flow chart (PALNM, paraaortic lymph node metastasis)
×
Table 1 shows the clinicopathological characteristics according to pathologic PALNM. Regarding preoperative characteristics, higher clinical T stage (cT4 29.0% vs. cT1 0.0%, cT2 3.2%, cT3 3.8%; p < 0.001), higher clinical N stage (cN2 17.6%, vs. cN0 2.1%, cN1 1.3%; p < 0.001), radiologic PALNM (42.4% vs. 2.2%, p < 0.001), and radiologic distant metastasis other than PALNM (31.8% vs. 5.0%, p < 0.001) were associated with a higher incidence of pathologic PALNM. Regarding pathologic characteristics, larger tumor size (> 5 cm), lymphovascular invasion and poor differentiation were associated with pathologic PALNM.
Table 1
Characteristics according to pathologic PALNM
Characteristics
Pathologic PALNM (−) (n = 244)
Pathologic PALNM (+) (n = 19)
p
Preoperative
Sex
Male
158 (94.0%)
10 (6.0%)
0.325
Female
86 (90.5%)
9 (9.5%)
Age (years)
63.61 ± 11.846
63.37 ± 10.761
0.931
BMI (kg/m2)
22.2 ± 2.7
22.2 ± 2.6
0.929
ASA
1, 2
224 (92.9%)
17 (7.1%)
0.665
3, 4
20 (90.9%)
2 (9.1%)
Preoperative
< 5
160 (94.7%)
9 (5.3%)
0.133
CEA (ng/mL)
≥ 5
82 (89.1%)
10 (10.9%)
Clinical T stage
cT1
13 (100%)
0 (0.0%)
< 0.001
cT2
30 (96.8%)
1 (3.2%)
cT3
179 (95.2%)
9 (4.8%)
cT4
22 (71.0%)
9 (29.0%)
Clinical N stage
cN0
94 (97.9%)
2 (2.1%)
< 0.001
cN1
75 (98.7%)
1 (1.3%)
cN2
75 (82.4%)
16 (17.6%)
Radiologic
Negative
225 (97.8%)
5 (2.2%)
< 0.001
PALNM
Positive
19 (57.6%)
14 (42.4%)
Radiologic DM
Negative
229 (95.0%)
12 (5.0%)
< 0.001
Other than PALNM
Positive
15 (68.2%)
7 (31.8%)
Tumor location
Colon
107 (93.0%)
8 (7.0%)
0.882
Rectum
137 (92.6%)
11 (7.4%)
Operative
Surgical procedure
Open
6 (60.0%)
4 (40.0%)
0.003
Laparoscopy
238 (94.1%)
15 (5.9%)
Operative time (min)
< 180
197 (93.8%)
13 (6.2%)
0.232
≥ 180
47 (88.7%)
6 (11.3%)
Pathologic
Tumor size (cm)
< 5
130 (96.3%)
5 (3.7%)
0.03
≥ 5
113 (89.0%)
14 (11.0%)
Lymphovascular
Negative
203 (97.6%)
5 (2.4%)
< 0.001
Invasion
Positive
41 (74.5%)
14 (25.5%)
Perineural
Negative
148 (94.9%)
8 (5.1%)
0.146
Invasion
Positive
96 (89.7%)
11 (10.3%)
Differentiation
w/d, m/d
227 (93.4%)
16 (6.6%)
0.031
p/d
7 (70.0%)
3 (30.0%)
Data are presented as mean ± standard deviation or number (percentage)
PALNM Paraaortic lymph node metastasis; BMI Body mass index; ASA American Society of Anesthesiologists; CEA Carcinoembryonic antigen; DM Distant metastasis; w/d Well differentiated; m/d Moderately differentiated; p/d Poorly differentiated
In multivariate analysis, radiologic PALNM (odds ratio [OR] 12.737, 95% confidence interval [CI] 3.472–46.723, p < 0.001) and radiologic distant metastasis other than PALNM (OR 4.090; 95% CI, 1.011–16.539; p = 0.048) were independent predictive factors for pathologic PALNM. However, higher clinical T stage and N stage were not predictive factors for pathologic PALNM in the multivariate analysis (Table 2).
Table 2
Multivariate analysis of predictive factors for pathologic PALNM
Variables
Pathologic PALNM
OR (95% CI)
p
Clinical T stage (cT4 vs. cT1–3)
3.182 (0.865–11.701)
0.081
Clinical N stage (cN2 vs. cN0–1)
2.705 (0.577–12.671)
0.207
Radiologic PALNM (positive vs. negative)
12.737 (3.472–46.723)
< 0.001
Radiologic DM other than PALNM (positive vs. negative)
4.090 (1.011–16.539)
0.048
PALNM Paraaortic lymph node metastasis; OR Odds ratio; CI Confidence interval; DM Distant metastasis
Table 3 shows postoperative complications. The overall 30-day morbidity rate was 18.2% (48/263), and the most common complication was prolonged postoperative ileus (6.8%). Anastomotic leakage occurred in 4.2% (11/263) of all the included patients. No postoperative mortality was recorded.
Table 3
Postoperative complications
Morbidity
n (%)
Total
48 (18.2%)
Bleeding
2 (0.8%)
Ileus
18 (6.8%)
Anastomotic leakage
11 (4.2%)
Urinary dysfunction
13 (4.9%)
Pneumonia
1 (0.4%)
Wound infection
6 (2.3%)
Deep SSI
5 (1.9%)
SSI Surgical site infection
Anzeige
Prognostic factors for OS are described in Table 4. In univariate survival analysis, pathologic T4 stage (37.3% vs. 82.1%, p < 0.001), pathologic N1-2 stage (65.8% vs. 87.7%, p = 0.001), M1 stage (38.8% vs.81.5%, p < 0.001), pathologic PALNM (54.0% vs. 78.6%, p = 0.002), and R2 resection (12.8% vs. 82.3%, p < 0.001) were associated with poorer OS (Table 4, Fig. 2a). Because M stage and R0 resection were highly correlated with each other (correlation coefficient = 0.727, p < 0.001), M stage was excluded from the multivariable survival analysis. In the multivariable analysis, pathologic T4 stage (hazard ratio [HR] 2.196, 95% CI 1.063–4.538, p = 0.034) and R0 resection (HR 4.643, 95% CI 2.046–10.534, p < 0.001) were independent prognostic factors for OS.
Table 4
Prognostic factors for overall survival by univariate and multivariate analyses
Variables
n
Univariate analysis
Multivariate analysis
5-year OS (%)
p
HR (95% CI)
p
Pathologic T stage
T4
49
37.6
< 0.001
2.196 (1.063–4.538)
0.034
T1–3
214
82.1
Pathologic N stage
N1-2
137
65.8
0.001
2.064 (0.961–4.434)
0.063
N0
126
87.7
M stage
M1
32
38.8
< 0.001
M0
231
81.5
pathologic palnm
Positive
19
54.0
0.002
1.367 (0.505–3.703)
0.538
Negative
244
78.6
R0 resection
R2
20
12.8
< 0.001
4.643 (2.046–10.534)
< 0.001
R0
243
82.3
OS Overall survival; HR hazard ratio; CI Confidence interval; PALNM Paraaortic lymph node metastasis
Fig. 2
Overall survival for (a) all patients according to pathologic paraaortic lymph node metastasis (PALNM); (b) patients with pathologic PALNM according to radicality of resection; (c) patients who underwent R0 resection according to pathologic PALNM
×
Among all included patients, 20 (7.6%) underwent R2 resection. Of 19 patients with pathologic PALNM, 9 patients (47.4%) underwent R0 resection and 10 patients (52.6%) underwent R2 resection. When comparing the survival outcome according to the radicality of resection in patients with PALNM, OS was significantly higher in patients undergoing R0 resection (5-year OS, 90.0% vs. 0.0%; p = 0.014) (Fig. 2b). In the subgroup analysis of patients who underwent R0 resection, no difference in 5-year OS (90.0% vs. 82.2%, p = 0.896) was found between patients with and without pathologic PALNM (Fig. 2c).
Discussion
In the present study, we investigated the necessity of PALND in patients with incidentally detected enlarged PALNs. The results showed that even in patients with no evidence of PALNM on preoperative radiologic examination, pathologic PALNM was identified in a small but non-negligible proportion (2.2%). Patients with pathologic PALNM showed poorer OS than those without pathologic PALNM. However, when R0 resection was achieved, patients with pathologic PALNM had comparable OS to those without pathologic PALNM.
PALNM is a known poor prognostic factor in patients with colorectal cancer [4‐7]. In cases of liver or lung metastasis, radical resection of the metastatic lesion is known to be beneficial for survival [10‐12]. However, there is no established standard treatment for PALNM, which is relatively rarer than liver or lung metastasis [7, 8, 13]. Recently, several studies have reported that PALND increased survival in patients with PALNM [6, 7, 13‐15]. For example, Choi et al. reported that the 5-year OS of the PALND group was significantly higher than that of the control group (53.4% vs. 12%, p = 0.045) [6]. Ogura et al. reported that the 5-year cancer-specific survival was significantly higher in the R0 resection group than in the control group with palliative resection in patients with extra-regional lymph node metastasis [16]. Gagniere et al. reported the outcome of radical retroperitoneal lymphadenectomy in patients with retroperitoneal nodal metastases from colorectal cancer [17]. They suggested that the 5-year OS of patients who underwent lymphadenectomy was significantly higher than that of patients treated with non-surgical treatment. However, some authors have reported that PALND is not recommended because of its technical difficulties and lack of survival benefit [18]. Others reported a high recurrence rate after PALND even when performed in selective patients with PALNM [19].
Anzeige
Determining the presence of PALNM through a preoperative imaging study before surgery and establishing an appropriate surgical plan are essential. In this study, radiologic PALNM was identified as a predictive factor for pathologic PALNM in the multivariable analysis. Nakai et al. evaluated the diagnostic value of CT and PET/CT in predicting PALNM [20]. When the diagnosis was based on CT combined with PET/CT, the diagnostic ability of PET/CT was 93.8% in patients who had no predictive CT findings. However, in patients with a suspected lesion on CT, the diagnostic ability of PET/CT was decreased to 70.6%. According to a study by Wong et al., among 264 patients suspected of having PALNM on radiologic examination, 118 patients showed positive PALNM in pathology, and the positive predictive value was only 44.7% [5]. Similarly, in the present study, the accuracy of preoperative imaging in predicting PALNM was 89.7%, whereas the positive predictive value was only 42.4%. Therefore, it is not easy to accurately diagnose PALNM based on preoperative imaging findings.
Surgeons often incidentally detect enlarged PALNs during surgery and deliberate about whether PALND should be performed. However, no standard treatment has been established for the management of incidentally detected enlarged PALNs in colorectal cancer patients. Importantly, in the present study, there were five (2.2%) false-negative cases in which PALNM was not detected on preoperative imaging but PALND was performed incidentally. In addition, a significant difference in OS was observed between the R0 and R2 resection groups (90.0% vs. 0.0%, p = 0.014). When R0 resection was achieved in patients with PALNM their OS was comparable to that of patients without PALNM (90.0% vs. 82.2%, p = 0.896). Therefore, we recommend performing PALND not only in patients with radiologically suspected PALNM but also in patients with enlarged PALNs incidentally detected during surgery, especially in patients with radiologic distant metastasis other than PALNM.
Frozen-section biopsy of an enlarged PALN may be helpful to decide whether to proceed with further PALND. In the present study, frozen-section biopsy was performed in only 11.0% (29/263) of patients, and 5 (17.2%) of them showed PALNM. Because the present study was retrospective, it was impossible to investigate whether the extent of surgery changed according to the result of frozen-section biopsy. However, given the fact that PALNM had not been found in 24 (83.8%) of the 29 patients with frozen-section biopsy, frozen-section biopsy may be helpful to avoid unnecessary wider PALND, preventing possible long-term complications.
Several studies have reported that retroperitoneal lymph node dissection is related to sexual dysfunction due to hypogastric nerve injury, chylous ascites, and lymphoceles [21, 22]. According to a systematic review by Wong et al. [5], the postoperative complication rate of PALND ranged from 7.8 to 33%. We observed a postoperative complication rate of 18.2%, with no postoperative mortality. The morbidity rate in the present study was comparable to that in our previous studies (13.9–31.2%) on rectal cancer surgery [23, 24]. PALND can be safely performed with minimal additional surgical complications.
Anzeige
This study had several limitations. First, this study was designed as a retrospective review of data from a single institution. Because PALND was decided and performed by four surgeons, the indication for PALND was not standardized, which might have led to a selection bias. Second, as the number of patients with pathologic PALNM was small, the results of the multivariate analysis need to be interpreted with caution. Third, we could not evaluate late complications such as ejaculatory dysfunction and reduced quality of life. Despite these limitations, the present study has a strength because very few studies have reported on the probability of pathologic PALNM in patients with incidentally detected PALNs.
Conclusion
The incidence of pathologic PALNM in patients with enlarged PALNs incidentally detected during colorectal cancer surgery was not negligible (2.2%). If R0 resection can be achieved, patients with PALNM can show a relatively good prognosis. Therefore, we recommend performing PALND when an enlarged PALN is incidentally detected during surgery for the purpose of R0 resection.
Acknowledgements
Not applicable
Ethics approval and consent to participate
This study was approved by the institutional review board of Chonnam National University Hwasun Hospital.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Prognostic significance of enlarged paraaortic lymph nodes detected during left-sided colorectal cancer surgery: a single-center retrospective cohort study
verfasst von
Jaram Lee Hyeong-min Park Soo Young Lee Chang Hyun Kim Hyeong Rok Kim
Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.
Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.
Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.
Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.
Update Chirurgie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.
